Effects of aerobic exercise on fibroblast growth factor 21 in overweight and obesity. A systematic review

Porflitt-Rodríguez M,; Guzmán-Arriagada V,; Sandoval-Valderrama R,; Tam CS,; Pavicic F,; Ehrenfeld P,; Martínez-Huenchullán S

Keywords: obesity, exercise, Fibroblast growth factor 21, Overweight.


Fibroblast growth factor 21 (FGF21) has been suggested to improve metabolism during aerobic exercise in obesity. However, the variability of exercise interventions gives rise to discrepancies in the field. Therefore, we aimed to systematically review the available literature regarding the effects of aerobic exercise on FGF21 in the context of overweight and obesity. Our search included original articles published between 2009 and November 2021 found in PubMed, Science Direct, and Medline. Clinical and preclinical studies were included. Studies, where subjects or animals presented with other conditions (e.g., cancer, stroke), were excluded. From an initial 43 studies, 19 (clinical studies = 9; preclinical studies = 10) were eligible for inclusion in this review. The main findings were that acute exercise tended to increase circulatory levels of FGF21. In contrast, chronic exercise programs (≥4 weeks) had the opposite effect along with inducing mRNA and protein increases of FGF receptors and β-klotho in adipose tissue, liver, and skeletal muscle. In conclusion, both clinical and preclinical studies showed that aerobic exercise exerts changes in circulatory and tissue FGF21, along with its receptors and co-receptor. Future research is needed to elucidate the mechanisms, along with the physiological and clinical implications of these changes.

Más información

Volumen: 129
Editorial: Elsevier
Fecha de publicación: 2022
Página de inicio: 155137
Idioma: INGLES
Notas: SCOPUS,